Lupin launches Formoflo G MDI, world's first fixed-dose triple-combination MDI for COPD, in India

Lupin has launched Formoflo G MDI in India, which it describes as the world's first fixed-dose triple-combination MDI for COPD, following approval from the DCGI.

Detected & updated continuously · Source: Nebula